According to the latest data from the Hong Kong Stock Exchange, on September 3rd, Chief Operating Officer Shao Weihui reduced her holdings in GENSCRIPT BIO (01548) by 115,538 shares at HK$17.3544 per share, with a total transaction value of approximately HK$2.0051 million. Following this reduction, her updated shareholding stands at approximately 6.8385 million shares, representing a stake of 0.31%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.